-
441
The development of a food-group, tree classification method and its use in exploring dietary associations with metabolic dysfunction-associated Steatotic liver disease (MASLD) and other health-related outcomes in a UK population
Published 2025-03-01Subjects: “…Fatty liver disease…”
Get full text
Article -
442
Mediterranean diet improves liver health but does not protect against azoxymethane-induced colon tumorigenesis compared to Western diet in A/J mice
Published 2025-03-01Subjects: “…Non-alcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
443
Spinach ameliorates dietary oxidized tallow-induced NAFLD by regulating inflammatory cytokines, peroxisome proliferator-activated receptors, and antioxidant systems
Published 2025-02-01Subjects: “…Nonalcoholic fatty liver disease…”
Get full text
Article -
444
COVID-19 in Patients with Primary Biliary Cholangitis
Published 2022-09-01Subjects: Get full text
Article -
445
The Renal and Liver Complications Development among Patients with Type 2 Diabetes Mellitus in Kirkuk City
Published 2022-06-01Subjects: Get full text
Article -
446
Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
447
Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Published 2021-01-01“…In this study, we aimed to verify plasma fibroblast growth factor 21 (FGF21) elevation in newly diagnosed overweight patients with type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) and to evaluate the effectiveness of liraglutide on reducing liver fat content and serum (FGF21) levels in those patients. …”
Get full text
Article -
448
Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway
Published 2020-01-01“…Kangtaizhi granule (KTZG) is a Chinese medicine compound prescription and has been proven to be effective in nonalcoholic fatty liver disease (NAFLD) treatment clinically. However, the underlying mechanisms under this efficacy are rather elusive. …”
Get full text
Article -
449
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention
Published 2025-01-01“…Abstract Metabolic dysfunction‐associated steatohepatitis (MASH) is a leading cause of chronic liver disease with few therapeutic options. To narrow the translational gap in the development of pharmacological MASH treatments, a 3D liver model from primary human hepatocytes and non‐parenchymal cells derived from patients with histologically confirmed MASH was established. …”
Get full text
Article -
450
Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis
Published 2025-02-01“…Therefore, this study aimed to investigate the effects of celastrol on the galaninergic system expression in the heart and liver of mice suffering from diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH).MethodsThe male mice C57BL/6J were fed a Western-type high-fat diet for 16 and 20 weeks to induce obesity and MASLD/MASH. …”
Get full text
Article -
451
The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet
Published 2018-01-01“…Coronary artery disease is the most common cause of death in the patients with nonalcoholic fatty liver disease (NAFLD). Studies have shown that there is a strong relation between the increase in the aminotransferase levels and fat accumulation in the liver with cardiovascular complications, independent of all aspects of the metabolic syndrome. …”
Get full text
Article -
452
A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease
Published 2025-01-01Subjects: “…Non-alcoholic fatty liver disease…”
Get full text
Article -
453
Effect of Metadoxine on Chronic Primary Hepatopathies in Canines: Number of Cases
Published 2023-09-01Subjects: “…liver diseases…”
Get full text
Article -
454
-
455
Occult hepatitis B virus infection: risk for a blood supply, but how about individuals’ health?
Published 2025-03-01Subjects: Get full text
Article -
456
Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents
Published 2025-02-01Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text
Article -
457
Lipotoxicity and metabolic disorders at obesity
Published 2010-02-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
458
Histopathological analysis of the liver in hypercholesterolemia rats treated with Dillenia serrata fruits
Published 2022-12-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
459
Cerebrovascular Accidents After Orthotopic Liver Transplantation in Patients with Hepatopulmonary Syndrome: A Case Series
Published 2024-12-01Subjects: Get full text
Article -
460
High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2
Published 2023-07-01Subjects: “…Nonalcoholic fatty liver disease…”
Get full text
Article